| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1081-1206(10)62275-2 |
| P698 | PubMed publication ID | 10795650 |
| P2093 | author name string | Lawrence M | |
| Lumry W | |||
| Corren J | |||
| Harrison JE | |||
| Nolop KB | |||
| Pearlman D | |||
| Segal AT | |||
| Floreani A | |||
| Hannaway PJ | |||
| Segall N | |||
| Scardella AT | |||
| Silverman B | |||
| Goldsobel A | |||
| Schenkel EJ | |||
| Munk Z | |||
| Nayak AS | |||
| Banov C | |||
| Shneyer L | |||
| Gottschlich GM | |||
| Lampl KL | |||
| Feinstein BK | |||
| Friedman BF | |||
| Lapidus RJ | |||
| P2860 | cites work | The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 |
| Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma | Q33605282 | ||
| The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells | Q34743332 | ||
| Measuring compliance with inhaled medication in asthma | Q35627983 | ||
| Inhaled glucocorticoids for asthma | Q40601265 | ||
| Glucocorticoids inhibit proliferation and interleukin-4 and interleukin-5 secretion by aeroallergen-specific T-helper type 2 cell lines | Q41029713 | ||
| A comparison of the efficacy and safety of inhaled corticosteroids in asthma | Q41559651 | ||
| Nonadherence in asthmatic patients: is there a solution to the problem? | Q41598381 | ||
| Efficacy and safety of inhaled corticosteroids. New developments | Q41728966 | ||
| A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma | Q46072941 | ||
| A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma | Q46354123 | ||
| Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study | Q46965854 | ||
| A scale for the measurement of quality of life in adults with asthma | Q48886332 | ||
| Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics. | Q52899269 | ||
| A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma. | Q53354854 | ||
| Once-daily budesonide in mild asthma | Q59361839 | ||
| Cytokine inhibition by a novel steroid, mometasone furoate | Q68042289 | ||
| Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients | Q71406890 | ||
| A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray | Q71696878 | ||
| Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma | Q73244325 | ||
| Glucocorticosteroids inhibit leukotriene production | Q73368962 | ||
| Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma | Q74493310 | ||
| Fluticasone propionate 50 micrograms BID versus 100 micrograms BID in the treatment of children with persistent asthma. Fluticasone Propionate Study Group | Q74776596 | ||
| P433 | issue | 4 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 417-424 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Annals of Allergy, Asthma & Immunology | Q13429696 |
| P1476 | title | Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma | |
| P478 | volume | 84 |
| Q43880002 | A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma |
| Q35072274 | A review of once-daily delivery of anti-asthmatic drugs in children |
| Q44927006 | Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate |
| Q32019428 | Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler |
| Q74105806 | Corticosteroid dosing and asthma control |
| Q43718488 | Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge |
| Q43602366 | Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator |
| Q48943114 | Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma |
| Q46786774 | Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma |
| Q35818440 | Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma |
| Q44998500 | Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate |
| Q42909622 | Efficacy and safety of two dry-powder inhalers for the administration of mometasone furoate in asthma patients |
| Q46289219 | Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis |
| Q33522061 | Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study |
| Q37313138 | Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma |
| Q36514174 | Inhaled mometasone furoate: A review of its use in persistent asthma in adults and adolescents |
| Q34340426 | Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma |
| Q24634033 | Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma |
| Q51138515 | Mometasone furoate (MF) improves lung function in pediatric asthma: A double-blind, randomized controlled dose-ranging trial of MF metered-dose inhaler. |
| Q34633474 | Mometasone furoate dry powder inhaler for the treatment of asthma |
| Q91705558 | Mometasone furoate for children with asthma: A meta-analysis |
| Q34621110 | Mometasone furoate in children with mild to moderate persistent asthma: a review of the evidence |
| Q24652990 | Mometasone furoate in the management of asthma: a review |
| Q26747719 | Mometasone furoate nasal spray: a systematic review |
| Q37556510 | Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children |
| Q43547471 | Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate |
| Q39351619 | Once-daily evening administration of mometasone furoate in asthma treatment initiation |
| Q37101342 | One-year treatment with mometasone furoate in chronic obstructive pulmonary disease |
| Q83554414 | Placebo effect model in asthma clinical studies: longitudinal meta-analysis of forced expiratory volume in 1 second |
| Q42603944 | Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma |
| Q73472044 | Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler |
| Q36684524 | The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma |
| Q35544762 | The impact of reducing dose frequency on health outcomes |
| Q36579819 | The systemic safety of inhaled corticosteroid therapy: a focus on ciclesonide |
Search more.